liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
MAINTENANCE BEVACIZUMAB (BV) WITH OR WITHOUT PEMETREXED (PEM) FOLLOWING FIRST-LINE BV-CISPLATIN (CIS)-PEM IN PATIENTS (PTS) WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC): PRELIMINARY SAFETY DATA FROM AVAPERL1 (MO22089) in ANNALS OF ONCOLOGY, vol 21, issue , pp 144-144
University Aix Marseille 2.
NN Blokhin Russian Canc Research Centre.
Natl Institute Canc Research, Genoa, Italy .
Dr M Koehler Gmbh.
Show others and affiliations
2010 (English)In: ANNALS OF ONCOLOGY, Oxford University Press , 2010, Vol. 21, 144-144 p.Conference paper, Published paper (Refereed)
Abstract [en]

n/a

Place, publisher, year, edition, pages
Oxford University Press , 2010. Vol. 21, 144-144 p.
National Category
Engineering and Technology
Identifiers
URN: urn:nbn:se:liu:diva-66328ISI: 000283115900445OAI: oai:DiVA.org:liu-66328DiVA: diva2:403205
Available from: 2011-03-11 Created: 2011-03-11 Last updated: 2011-03-11

Open Access in DiVA

No full text

Authority records BETA

Vikström, Anders

Search in DiVA

By author/editor
Vikström, Anders
By organisation
Department of Clinical and Experimental MedicineFaculty of Health Sciences
Engineering and Technology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 93 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf